Lancet Oncology

Oncology & Cancer

New immune-stimulating drug, with chemo, shrinks pancreas tumors

The results of an early-stage (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to data published in The ...

Oncology & Cancer

Light therapy effectively treats early prostate cancer

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech ...

Oncology & Cancer

The first epigenetic test to diagnose tumors of unknown origin

In patients with cancer, initial diagnosis most often includes the detection of the primary or original tumor and the presence or absence of metastases, ie cells from the original tumor that have escaped from their original ...

Oncology & Cancer

Sex hormones linked to breast cancer risk in women under 50

Premenopausal women with high levels of sex hormones in their blood have an increased risk of breast cancer, an Oxford University study suggests, though further research is needed to understand this link.

page 4 from 39